AbCellera Biologics Inc.
ABCL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$163 | -$146 | $159 | $153 |
| Dep. & Amort. | $97 | $31 | $33 | $17 |
| Deferred Tax | $0 | $2 | -$2 | -$2 |
| Stock-Based Comp. | $68 | $64 | $49 | $0 |
| Change in WC | -$26 | $13 | $30 | $42 |
| Other Non-Cash | -$84 | -$8 | $9 | $34 |
| Operating Cash Flow | -$109 | -$44 | $277 | $245 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$78 | -$78 | -$73 | -$58 |
| Net Acquisitions | -$20 | -$14 | -$26 | -$11 |
| Inv. Purchases | -$765 | -$1,066 | -$781 | -$323 |
| Inv. Sales/Matur. | $949 | $911 | $511 | $28 |
| Other Inv. Act. | $36 | $25 | $16 | $33 |
| Investing Cash Flow | $121 | -$221 | -$353 | -$332 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $13 | $12 | $3 | -$1 |
| Stock Issued | $0 | $0 | $0 | $5 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$1 | -$4 | -$8 |
| Financing Cash Flow | $13 | $10 | -$2 | -$4 |
| Forex Effect | -$3 | $1 | -$10 | -$1 |
| Net Chg. in Cash | $23 | -$254 | -$86 | -$93 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $161 | $415 | $501 | $594 |
| End Cash | $184 | $161 | $415 | $501 |
| Free Cash Flow | -$187 | -$121 | $205 | $186 |